Commercialization and health ecomomics and outcomes research (HEOR) strategies for therapeutics development are changing constantly, due to the current commerical success rate for pharma and biotech and medical device industries, as well as the often referenced, looming patent cliff. Commercialization topics are covered in a wide range of webinars on this page – from pharmacoeconomics, access challenges and strategic alliances, to employing drug models to determine commericalization strategy.